Prosecution Insights
Prosecution Insights
5 pending office actions • 5 clients • 5 examiners • 4 art units • 0 of 5 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §112 only | 1 (20%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKER, JOSEPH D | 1 | 83.6% | +22.8% |
| HELM, CARALYNNE E | 1 | 28.8% | +49.6% |
| BREEN, KIMBERLY CATHERINE | 1 | 24.4% | +56.7% |
| BECKHARDT, LYNDSEY MARIE | 1 | 27.9% | +48.0% |
| DUTT, ADITI | 1 | 47.1% | +48.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18683221 | FACE MASKS AND BAG-VALVE MASK RESUSCITATOR SYSTEMS FOR VENTILATION OF PATIENTS | BOECKER, JOSEPH D | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18426299 | SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT | HELM, CARALYNNE E | 105d overdue |
| 17676085 | Therapeutic Protein Formulations | DUTT, ADITI | 16d overdue |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | BECKHARDT, LYNDSEY MARIE | 56d |
| 18267990 | METHOD FOR PRODUCING HUMAN COLLAGEN STRUCTURES WITH CONTROLLED CHARACTERISTICS | BREEN, KIMBERLY CATHERINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18426299 | SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT | HELM, CARALYNNE E | 105d overdue |
| 17676085 | Therapeutic Protein Formulations | DUTT, ADITI | 16d overdue |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | BECKHARDT, LYNDSEY MARIE | 56d |
| 18683221 | FACE MASKS AND BAG-VALVE MASK RESUSCITATOR SYSTEMS FOR VENTILATION OF PATIENTS | BOECKER, JOSEPH D | — |
| 18267990 | METHOD FOR PRODUCING HUMAN COLLAGEN STRUCTURES WITH CONTROLLED CHARACTERISTICS | BREEN, KIMBERLY CATHERINE | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Spirare Medical LLC | 1 |
| Biocorrx | 1 |
| José Adán ORTEGA BLANCO | 1 |
| University of Connecticut | 1 |
| Gloriana Therapeutics, Inc. | 1 |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| 1657 | 1 |
| 1613 | 1 |
| 1675 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18683221 | FACE MASKS AND BAG-VALVE MASK RESUSCITATOR SYSTEMS FOR VENTILATION OF PATIENTS | Spirare Medical LLC | BOECKER, JOSEPH D | §112 | Non-Final OA | — | Pending | Feb 12, 2024 | |
| 18426299 | SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT | Biocorrx | HELM, CARALYNNE E | 1615 | §103§112 | Non-Final OA | 105d overdue | Pending | Jan 29, 2024 |
| 18267990 | METHOD FOR PRODUCING HUMAN COLLAGEN STRUCTURES WITH CONTROLLED CHARACTERISTICS | José Adán Ortega Blanco | BREEN, KIMBERLY CATHERINE | 1657 | §103§112 | Final Rejection | — | Pending | Jun 16, 2023 |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | UNIVERSITY OF CONNECTICUT | BECKHARDT, LYNDSEY MARIE | 1613 | §102§103Other | Final Rejection | 56d | Pending | Apr 05, 2023 |
| 17676085 | Therapeutic Protein Formulations | Gloriana Therapeutics, Inc. | DUTT, ADITI | 1675 | §101§102§112 | Non-Final OA | 16d overdue | Pending | Feb 18, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial